2023 Q1 Form 10-K Financial Statement
#000092416823000035 Filed on March 23, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 Q3 |
---|---|---|---|
Revenue | $930.0K | $663.0K | $1.764M |
YoY Change | -54.88% | -72.43% | -35.83% |
Cost Of Revenue | $913.0K | $901.0K | $1.927M |
YoY Change | -56.25% | -59.34% | -11.85% |
Gross Profit | $17.00K | -$238.0K | -$163.0K |
YoY Change | -165.38% | -225.93% | -128.95% |
Gross Profit Margin | 1.83% | -35.9% | -9.24% |
Selling, General & Admin | $1.066M | $1.255M | $1.802M |
YoY Change | -49.88% | -39.69% | -8.43% |
% of Gross Profit | 6270.59% | ||
Research & Development | $154.0K | $269.0K | $366.0K |
YoY Change | -69.38% | -42.03% | -9.41% |
% of Gross Profit | 905.88% | ||
Depreciation & Amortization | $8.000K | $30.00K | $42.00K |
YoY Change | -81.82% | -33.33% | -2.33% |
% of Gross Profit | 47.06% | ||
Operating Expenses | $1.220M | $1.524M | $2.244M |
YoY Change | -53.61% | -40.12% | -5.44% |
Operating Profit | -$1.203M | -$1.762M | -$2.407M |
YoY Change | -54.71% | -25.21% | 32.98% |
Interest Expense | $123.0K | -$275.0K | $235.0K |
YoY Change | -33.15% | 1.1% | 32.77% |
% of Operating Profit | |||
Other Income/Expense, Net | -$7.000K | $69.00K | -$96.00K |
YoY Change | -36.36% | -483.33% | 540.0% |
Pretax Income | -$1.333M | -$2.306M | -$2.662M |
YoY Change | -52.75% | -12.39% | 133.51% |
Income Tax | $4.000K | ||
% Of Pretax Income | |||
Net Earnings | -$1.333M | -$2.310M | -$2.662M |
YoY Change | -52.75% | -12.2% | 133.51% |
Net Earnings / Revenue | -143.33% | -348.42% | -150.91% |
Basic Earnings Per Share | -$0.23 | -$0.29 | |
Diluted Earnings Per Share | -$0.08 | -$0.23 | -$289.7K |
COMMON SHARES | |||
Basic Shares Outstanding | 18.13M shares | 9.577M shares | 9.190M shares |
Diluted Shares Outstanding | 16.17M shares | 9.583M shares | 9.190M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $916.0K | $644.0K | $651.0K |
YoY Change | -1.08% | -81.03% | -49.69% |
Cash & Equivalents | $301.0K | $100.0K | $41.00K |
Short-Term Investments | $615.0K | $592.0K | $610.0K |
Other Short-Term Assets | $226.0K | $0.00 | $788.0K |
YoY Change | -75.14% | -100.0% | -44.55% |
Inventory | $4.938M | $5.476M | $6.156M |
Prepaid Expenses | |||
Receivables | $909.0K | $445.0K | $1.007M |
Other Receivables | $445.0K | $445.0K | $0.00 |
Total Short-Term Assets | $7.434M | $7.242M | $8.602M |
YoY Change | -29.42% | -46.05% | -28.9% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.179M | $1.256M | $1.681M |
YoY Change | -41.55% | 29.89% | 66.93% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $1.179M | $1.256M | $1.681M |
YoY Change | -41.55% | 29.89% | 66.93% |
TOTAL ASSETS | |||
Total Short-Term Assets | $7.434M | $7.242M | $8.602M |
Total Long-Term Assets | $1.179M | $1.256M | $1.681M |
Total Assets | $8.613M | $8.498M | $10.28M |
YoY Change | -31.37% | -40.95% | -21.53% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.177M | $2.204M | $1.886M |
YoY Change | -2.38% | -1.39% | -27.63% |
Accrued Expenses | $841.0K | $863.0K | $1.019M |
YoY Change | -41.43% | -51.08% | -39.92% |
Deferred Revenue | $7.000K | ||
YoY Change | 250.0% | ||
Short-Term Debt | $388.0K | $2.261M | $1.976M |
YoY Change | -87.52% | 4.24% | -25.88% |
Long-Term Debt Due | $1.277M | $2.618M | $1.972M |
YoY Change | 9.99% | 52.21% | 23.02% |
Total Short-Term Liabilities | $4.683M | $7.946M | $6.860M |
YoY Change | -40.99% | -2.57% | -19.98% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $815.0K |
YoY Change | |||
Other Long-Term Liabilities | $975.0K | $1.029M | $1.082M |
YoY Change | -17.44% | 3857.69% | 3506.67% |
Total Long-Term Liabilities | $975.0K | $1.029M | $1.897M |
YoY Change | -17.44% | 3857.69% | 6223.33% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.683M | $7.946M | $6.860M |
Total Long-Term Liabilities | $975.0K | $1.029M | $1.897M |
Total Liabilities | $5.658M | $8.975M | $8.757M |
YoY Change | -37.94% | 9.69% | 1.79% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$150.4M | -$149.0M | -$146.7M |
YoY Change | 6.21% | 7.41% | 7.79% |
Common Stock | $153.3M | $148.5M | $148.2M |
YoY Change | 5.74% | 2.48% | 5.42% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.955M | $1.500M | $1.526M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $8.613M | $8.498M | $10.28M |
YoY Change | -31.37% | -40.95% | -21.53% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.333M | -$2.310M | -$2.662M |
YoY Change | -52.75% | -12.2% | 133.51% |
Depreciation, Depletion And Amortization | $8.000K | $30.00K | $42.00K |
YoY Change | -81.82% | -33.33% | -2.33% |
Cash From Operating Activities | -$1.200M | -$472.0K | -$891.0K |
YoY Change | -55.6% | -64.91% | -61.51% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | $9.000K |
YoY Change | -100.0% | -100.0% | -91.0% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $25.00K | ||
YoY Change | |||
Cash From Investing Activities | $0.00 | $25.00K | -$9.000K |
YoY Change | -100.0% | -118.94% | -91.0% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $1.432M | 458.0K | $3.000K |
YoY Change | 409.61% | -87.88% | -99.73% |
NET CHANGE | |||
Cash From Operating Activities | -$1.200M | -472.0K | -$891.0K |
Cash From Investing Activities | $0.00 | 25.00K | -$9.000K |
Cash From Financing Activities | $1.432M | 458.0K | $3.000K |
Net Change In Cash | $249.0K | 11.00K | -$897.0K |
YoY Change | -110.13% | -99.52% | -30.36% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.200M | -$472.0K | -$891.0K |
Capital Expenditures | $0.00 | $0.00 | $9.000K |
Free Cash Flow | -$1.200M | -$472.0K | -$900.0K |
YoY Change | -56.17% | -61.09% | -62.73% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000924168 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
ENERGY FOCUS, INC/DE | |
CY2020Q1 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.2 | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
9500000 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
18133100 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
1808 | |
CY2022 | dei |
Auditor Name
AuditorName
|
GBQ Partners, LLC | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Columbus, Ohio | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
52000 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2682000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
26000 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
14000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
445000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1240000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
5476000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
7866000 | usd |
CY2022Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
592000 | usd |
CY2021Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
712000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
232000 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
479000 | usd |
CY2022Q4 | efoi |
Receivable For Claimed Employee Retention Tax Credit Current
ReceivableForClaimedEmployeeRetentionTaxCreditCurrent
|
445000 | usd |
CY2021Q4 | efoi |
Receivable For Claimed Employee Retention Tax Credit Current
ReceivableForClaimedEmployeeRetentionTaxCreditCurrent
|
445000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
7242000 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13424000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
76000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
675000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1180000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
292000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
8498000 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
14391000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2204000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2235000 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
145000 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
265000 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
104000 | usd |
CY2022Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
261000 | usd |
CY2021Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
718000 | usd |
CY2022Q4 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
76000 | usd |
CY2021Q4 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
57000 | usd |
CY2022Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
183000 | usd |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
295000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
268000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
198000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
325000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
1000 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2618000 | usd |
CY2021Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1719000 | usd |
CY2022Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
814000 | usd |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1447000 | usd |
CY2021Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
2169000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7946000 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8156000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1029000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
26000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
8975000 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
8182000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
876447 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
876447 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
876447 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
876447 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9848438 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9848438 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6368549 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6368549 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
148545000 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
144953000 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-3000 | usd |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-3000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-149020000 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-138741000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-477000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6209000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8498000 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14391000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
5968000 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
9865000 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6286000 | usd |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
8167000 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
-318000 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
1698000 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1891000 | usd |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
338000 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2022 | us-gaap |
Restructuring Costs
RestructuringCosts
|
0 | usd |
CY2021 | us-gaap |
Restructuring Costs
RestructuringCosts
|
-21000 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
8977000 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8707000 | usd |
CY2022 | efoi |
Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
|
0 | usd |
CY2021 | efoi |
Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
|
801000 | usd |
CY2022 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
56000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10275000 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-7887000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-1.27 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-1.27 | |
CY2021 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-1.73 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8110000 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8110000 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4561000 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4561000 | shares |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10279000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7886000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
0 | usd |
CY2021 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
0 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-10279000 | usd |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7886000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
80000 | usd |
CY2021 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
9500000 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
969000 | usd |
CY2021 | us-gaap |
Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
|
801000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7886000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6209000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
6000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3500000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
334000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
117000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
|
304000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10279000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-477000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10279000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7886000 | usd |
CY2022 | efoi |
Gain Loss From Employee Retention Tax Credit
GainLossFromEmployeeRetentionTaxCredit
|
30000 | usd |
CY2021 | efoi |
Gain Loss From Employee Retention Tax Credit
GainLossFromEmployeeRetentionTaxCredit
|
876000 | usd |
CY2022 | efoi |
Interest Paid Including Capitalized Interest Operating Activities
InterestPaidIncludingCapitalizedInterestOperatingActivities
|
40000 | usd |
CY2021 | efoi |
Interest Paid Including Capitalized Interest Operating Activities
InterestPaidIncludingCapitalizedInterestOperatingActivities
|
0 | usd |
CY2022 | efoi |
Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
|
0 | usd |
CY2021 | efoi |
Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
|
801000 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
159000 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
188000 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
117000 | usd |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
429000 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
14000 | usd |
CY2021 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
6000 | usd |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
32000 | usd |
CY2021 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
156000 | usd |
CY2022 | efoi |
Increase Decrease In Provision For Warranties
IncreaseDecreaseInProvisionForWarranties
|
-111000 | usd |
CY2021 | efoi |
Increase Decrease In Provision For Warranties
IncreaseDecreaseInProvisionForWarranties
|
68000 | usd |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
364000 | usd |
CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
230000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-338000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-783000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-783000 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2358000 | usd |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2381000 | usd |
CY2022 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-120000 | usd |
CY2021 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-257000 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-247000 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-669000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-423000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-596000 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-380000 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-268000 | usd |
CY2021 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
196000 | usd |
CY2022 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
3566000 | usd |
CY2021 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
-1879000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6713000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9765000 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
41000 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
443000 | usd |
CY2022 | us-gaap |
Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
|
25000 | usd |
CY2021 | us-gaap |
Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
|
0 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-16000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-443000 | usd |
CY2022 | efoi |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
3500000 | usd |
CY2021 | efoi |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
9500000 | usd |
CY2022 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | usd |
CY2021 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
801000 | usd |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
334000 | usd |
CY2021 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
969000 | usd |
CY2022 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1000 | usd |
CY2021 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
3000 | usd |
CY2022 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
6000 | usd |
CY2021 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
80000 | usd |
CY2022 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | usd |
CY2021 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1000 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
800000 | usd |
CY2021 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | |
CY2022 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
114000 | usd |
CY2021 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
30000 | usd |
CY2022 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-768000 | usd |
CY2021 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-181000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4099000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10712000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2630000 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
504000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2682000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2178000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
52000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2682000 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
364000 | usd |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
381000 | usd |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1000 | usd |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
4000 | usd |
CY2022 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
304000 | usd |
CY2021 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
0 | usd |
CY2022 | us-gaap |
Nature Of Operations
NatureOfOperations
|
NATURE OF OPERATIONS <div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient lighting systems and controls. We develop, market and sell high quality light-emitting diode (“LED”) lighting and controls products in the commercial market and military maritime market (“MMM”), and began to expand our offerings into the consumer market in the fourth quarter of 2021. Our mission is to enable our customers to run their facilities, offices with greater energy efficiency, productivity, and human health and wellness through advanced LED retrofit solutions. Our goal is to be the human wellness lighting and LED technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military-grade tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial and consumer applications. In late 2020, we announced the launch of ultraviolet-C light disinfection (“UVCD”) products. After evaluating market demand and supply chain challenges for our UVCD products, we revised our business strategy to primarily focus on our MMM and commercial and industrial lighting and control products. We are also evaluating adjacent technologies including Gallium Nitride (“GaN”) based power supplies and additional market opportunities in energy solution products that promote sustainability.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LED lighting industry has changed dramatically over the past several years due to increasing competition and price erosion. We have been experiencing these industry forces in both our military business since 2016 and in our commercial segment, where we once commanded significant price premiums for our flicker-free TLEDs with primarily 10-year warranties. In more recent years, we have focused on redesigning our products for lower costs and consolidated our supply chain for stronger purchasing power in an effort to price our products more competitively. Despite these efforts, our legacy products continue to face aggressive pricing competition and a convergence of product functionality in the marketplace, and we have shifted to diversifying our supply chain in an effort to increase value and remain competitive. These trends are not unique to Energy Focus as evidenced by the increasing number of industry peers facing challenges, exiting LED lighting, selling assets and even going out of business.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to continuously pursuing cost reductions, our strategy to combat these trends is to innovate both our technology and product offerings with differentiated products and solutions that offer greater, distinct value. Specific examples of these</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products we have developed include the RedCap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our emergency backup battery integrated TLED, EnFocus™, our new dimmable/color-tunable lighting and powerline control platform that we launched in 2020, and the second generation of EnFocus™ powerline control switches and circadian lighting system for both commercial and residential markets, which as a result of supply chain challenges we now plan to launch in 2023. Similarly, our plans to expand and enhance the performance of our RedCap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product line are also now expected in 2023. We continue to evaluate our sales strategy and believe our go-to-market strategy that focuses more on direct-sales marketing, selectively expanding our channel partner network to cover territories across the country, and listening to the voice of the customer, will lead to better and more impactful product development efforts that we believe will eventually translate into larger addressable markets and greater sales growth for us.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced significant sales declines, operating losses and increases in its inventory. Beginning in 2019, significant restructuring efforts were undertaken. The Company replaced the entire senior management team, significantly reduced non-critical expenses, minimized the amount of inventory the Company was purchasing, dramatically changed the composition of our board of directors (“Board of Directors”) and the executive team, and recruited new departmental leaders across the Company. The initial cost savings efforts to reduce costs to minimize cash usage included the elimination of certain positions, restructuring of the sales organization and incentive plan, flattening of the senior management team, additional operational streamlining, management compensation reductions, and outsourcing of certain functions including certain elements of supply chain and marketing.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2022, we realized initial cost-savings benefits from these relaunch efforts, but continued to face significant operating losses. Despite these cost-cutting efforts, the company faced a challenging commercial market with continuing impacts from the global pandemic combined with ongoing delays in MMM projects and funding that continued to depress sales through 2021 while the company invested in exploring additional lines of business with UVCD technology that ultimately gained little traction in the market.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the beginning of 2022, the board of directors appointed our lead independent director to serve as interim chief executive officer and replace our previous chief executive officer. During 2022, the company expanded its cost-reduction efforts, reduced its warehouse square footage, undertook an inventory reduction project, and dramatically reduced head count. In February and September of 2022, we also added three experienced executives to our Board of Directors with extensive lighting and consumer </span></div>products industry experience. We reinvested in our MMM sales channel with a strategic hire in May 2022 and continue to pursue these sales opportunities, though the sales cycles for what are frequently made-to-order products are longer than commercial offerings. | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods presented. Estimates include, but are not limited to, the establishment of reserves for accounts receivable, sales returns, inventory excess and obsolescence reserve and warranty claims, the useful lives for property and equipment and stock-based compensation. In addition, estimates and assumptions associated with the determination of the fair value of financial instruments and evaluation of long-lived assets for impairment requires considerable judgment. Actual results could differ from those estimates and such differences could be material.</span></div> | |
CY2022Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
471000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
1254000 | usd |
CY2020Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
2029000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
26000 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
14000 | usd |
CY2020Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
8000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
445000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1240000 | usd |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2021000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
100000 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2700000 | usd |
CY2022 | efoi |
Increase Decrease In Inventory Levels Gross
IncreaseDecreaseInInventoryLevelsGross
|
2900000 | usd |
CY2022 | efoi |
Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
|
500000 | usd |
CY2021 | efoi |
Increase Decrease In Inventory Levels Gross
IncreaseDecreaseInInventoryLevelsGross
|
2400000 | usd |
CY2021 | efoi |
Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
|
200000 | usd |
CY2022 | efoi |
Contract With Customer Payment Terms
ContractWithCustomerPaymentTerms
|
P30D | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7886000 | usd |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
8110000 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
8110000 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4561000 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4561000 | shares |
CY2022 | us-gaap |
Depreciation
Depreciation
|
200000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10279000 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
300000 | usd |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
400000 | usd |
CY2022 | efoi |
Product Warranty Number Of Products Sold
ProductWarrantyNumberOfProductsSold
|
1 | product |
CY2022 | efoi |
Product Warranty Number Of Years For Product Sold
ProductWarrantyNumberOfYearsForProductSold
|
P20Y | |
CY2022 | efoi |
Product Warranty Number Of Contracts Expired
ProductWarrantyNumberOfContractsExpired
|
1 | contract |
CY2022 | efoi |
Product Warranty Number Of Years For Expired Contract
ProductWarrantyNumberOfYearsForExpiredContract
|
P10Y | |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
295000 | usd |
CY2020Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
227000 | usd |
CY2022 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
24000 | usd |
CY2021 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
-41000 | usd |
CY2022 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
-136000 | usd |
CY2021 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
47000 | usd |
CY2022 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
0 | usd |
CY2021 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
62000 | usd |
CY2022Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
183000 | usd |
CY2021Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
295000 | usd |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
423000 | usd |
CY2021 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
532000 | usd |
CY2022 | efoi |
Restructured Leases Operating Lease Payments
RestructuredLeasesOperatingLeasePayments
|
0 | usd |
CY2021 | efoi |
Restructured Leases Operating Lease Payments
RestructuredLeasesOperatingLeasePayments
|
35000 | usd |
CY2022 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1000 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain risks and concentrations</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our products were sold through a direct sales model, which included a combination of direct sales employees, electrical and lighting contractors, and distributors. From time to time, we have utilized a third-party accounts receivable insurance and credit assessment company. Although we maintain allowances for potential credit losses that we believe to be adequate, a payment default on a significant sale could materially and adversely affect our operating results and financial condition, although we have mitigated this risk somewhat through the accounts receivable insurance program.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable, as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In 2022, two customers accounted for 27% of net sales, with sales to our primary distributor for the U.S. Navy accounting for approximately 13% and sales to a regional commercial lighting retrofit company accounting for approximately 14% of net sales. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 30% of net sales for the same period. In 2021, two customers accounted for 43% of net sales, with sales to our primary distributor for the U.S. Navy accounting for approximately 30% and sales to a regional commercial lighting retrofit company accounting for approximately 13% of net sales. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 38% of net sales for the same period. </span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">At December 31, 2022, a distributor to the U.S. Department of Defense accounted for 25% of our net trade accounts receivable, when combined with our net trade accounts receivable to shipbuilders for the U.S. Navy, total net accounts receivable related to U.S. Navy sales is 30% of total net accounts receivable. At December 31, 2021, a distributor to the U.S. Department of Defense accounted for 20% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 36% of our net trade accounts receivable. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require substantial amounts of purchased materials from selected vendors. With specific materials, all of our purchases are from a single vendor. The availability and costs of materials may be subject to change due to, among other things, new laws or regulations, suppliers’ allocation to other purchasers, interruptions in production by suppliers, global health issues such as the COVID-19 pandemic, and changes in exchange rates and worldwide price and demand levels. Our inability to obtain adequate supplies of materials for our products at favorable prices could have a material adverse effect on our business, financial position, or results of operations by decreasing our profit margins and by hindering our ability to deliver products to our customers on a timely basis. Additionally, certain vendors require advance deposits prior to the fulfillment of orders. Deposits paid on unfulfilled orders totaled $0.6 million and $0.7 million at December 31, 2022 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain vendors who individually represented 10% or more of our total expenditures, or whose net trade accounts payable balance individually represented 10% or more of our total net trade accounts payable, as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">One offshore supplier accounted for approximately 16% of our total expenditures for the twelve months ended December 31, 2022. At December 31, 2022, this same offshore supplier accounted for approximately 36% of our trade accounts payable balance.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">One offshore supplier accounted for approximately 29% of our total expenditures for the twelve months ended December 31, 2021. At December 31, 2021, this same offshore supplier accounted for approximately 60% of our trade accounts payable balance.</span></div> | |
CY2022Q4 | us-gaap |
Supplies
Supplies
|
600000 | usd |
CY2021Q4 | us-gaap |
Supplies
Supplies
|
700000 | usd |
CY2022Q4 | efoi |
Lessee Operating Lease Interest Rate Effective Rate
LesseeOperatingLeaseInterestRateEffectiveRate
|
0.1593 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.0725 | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y4M24D | |
CY2022 | us-gaap |
Sublease Income
SubleaseIncome
|
90000 | usd |
CY2021 | us-gaap |
Sublease Income
SubleaseIncome
|
112000 | usd |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
501000 | usd |
CY2021 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
558000 | usd |
CY2022 | efoi |
Operating Lease Cost Net Of Sublease Income
OperatingLeaseCostNetOfSubleaseIncome
|
411000 | usd |
CY2021 | efoi |
Operating Lease Cost Net Of Sublease Income
OperatingLeaseCostNetOfSubleaseIncome
|
446000 | usd |
CY2022 | efoi |
Restructured Lease Sublease Income
RestructuredLeaseSubleaseIncome
|
0 | usd |
CY2021 | efoi |
Restructured Lease Sublease Income
RestructuredLeaseSubleaseIncome
|
136000 | usd |
CY2022 | efoi |
Restructured Lease Operating Lease Cost
RestructuredLeaseOperatingLeaseCost
|
0 | usd |
CY2021 | efoi |
Restructured Lease Operating Lease Cost
RestructuredLeaseOperatingLeaseCost
|
110000 | usd |
CY2022 | efoi |
Restructured Lease Operating Lease Cost Net Of Sublease Income
RestructuredLeaseOperatingLeaseCostNetOfSubleaseIncome
|
0 | usd |
CY2021 | efoi |
Restructured Lease Operating Lease Cost Net Of Sublease Income
RestructuredLeaseOperatingLeaseCostNetOfSubleaseIncome
|
-26000 | usd |
CY2022 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
1000 | usd |
CY2021 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
0 | usd |
CY2022 | efoi |
Finance Lease Cost Net
FinanceLeaseCostNet
|
1000 | usd |
CY2021 | efoi |
Finance Lease Cost Net
FinanceLeaseCostNet
|
0 | usd |
CY2022 | us-gaap |
Lease Cost
LeaseCost
|
412000 | usd |
CY2021 | us-gaap |
Lease Cost
LeaseCost
|
420000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10300000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7900000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6700000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9800000 | usd |
CY2022Q3 | efoi |
Common Stock Closing Bid Price Threshold
CommonStockClosingBidPriceThreshold
|
1.00 | |
CY2022Q3 | efoi |
Number Of Consecutive Days For Bid Price Below Threshold
NumberOfConsecutiveDaysForBidPriceBelowThreshold
|
30 | d |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2500000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1500000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1180000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
292000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1227000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
351000 | usd |
CY2022Q4 | efoi |
Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
|
13000 | usd |
CY2021Q4 | efoi |
Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
|
13000 | usd |
CY2022Q4 | efoi |
Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
|
13000 | usd |
CY2021Q4 | efoi |
Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
|
12000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
0 | usd |
CY2021Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
1000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | usd |
CY2021Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
1000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | usd |
CY2021Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
1000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
|
386000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
|
379000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
|
385000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
|
390000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
|
197000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1737000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
510000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1227000 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3347000 | usd |
CY2021Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3882000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
4656000 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
7034000 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
2527000 | usd |
CY2021Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
3050000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
5476000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
7866000 | usd |
CY2020Q4 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2894000 | usd |
CY2022 | efoi |
Inventory Valuation Reserves Provision Accrual
InventoryValuationReservesProvisionAccrual
|
-312000 | usd |
CY2021 | efoi |
Inventory Valuation Reserves Provision Accrual
InventoryValuationReservesProvisionAccrual
|
-281000 | usd |
CY2022 | efoi |
Inventory Valuation Reserves Sales Of Inventory
InventoryValuationReservesSalesOfInventory
|
323000 | usd |
CY2021 | efoi |
Inventory Valuation Reserves Sales Of Inventory
InventoryValuationReservesSalesOfInventory
|
125000 | usd |
CY2022 | efoi |
Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
|
512000 | usd |
CY2021 | efoi |
Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
|
0 | usd |
CY2022Q4 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2527000 | usd |
CY2021Q4 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
3050000 | usd |
CY2022 | efoi |
Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
|
500000 | usd |
CY2022 | efoi |
Increase Decrease In Inventory Levels Gross
IncreaseDecreaseInInventoryLevelsGross
|
2900000 | usd |
CY2021 | efoi |
Increase Decrease In Inventory Levels Gross
IncreaseDecreaseInInventoryLevelsGross
|
2400000 | usd |
CY2021 | efoi |
Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
|
200000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
|
0 | usd |
CY2021Q4 | us-gaap |
Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
|
13000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
1392000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
3477000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
1316000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
2802000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
76000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
675000 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
200000 | usd |
CY2022 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
334000 | usd |
CY2021 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
0 | usd |
CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
63000 | usd |
CY2021Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
131000 | usd |
CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
130000 | usd |
CY2021Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
253000 | usd |
CY2022Q4 | us-gaap |
Prepaid Rent
PrepaidRent
|
39000 | usd |
CY2021Q4 | us-gaap |
Prepaid Rent
PrepaidRent
|
74000 | usd |
CY2022Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
0 | usd |
CY2021Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
18000 | usd |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
232000 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
479000 | usd |
CY2020Q3 | efoi |
Debt Instrument Number Of Credit Facilities
DebtInstrumentNumberOfCreditFacilities
|
2 | creditfacility |
CY2022Q2 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
1800000 | usd |
CY2021 | efoi |
Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
|
801000 | usd |
CY2022Q4 | us-gaap |
Purchase Obligation
PurchaseObligation
|
600000 | usd |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
237892 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
226960 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.95 | |
CY2020Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2020Q1 | efoi |
Percentage Of Series A Preferred Stock Eligible To Vote
PercentageOfSeriesAPreferredStockEligibleToVote
|
0.1107 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
117000 | usd |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
429000 | usd |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
100000 | usd |
CY2021Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
300000 | usd |
CY2022 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y9M18D | |
CY2021 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y8M12D | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
221450 | shares |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.45 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
88240 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.07 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
36706 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.35 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
1650 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
49.18 | |
CY2021 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
4225 | shares |
CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.96 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
267109 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.46 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
160778 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
2.99 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
2233 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
2.78 | |
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
250 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.45 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
276267 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
2.13 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
117542 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.13 | |
CY2022 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
250 | shares |
CY2021 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
4225 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
330808 | shares |
CY2022 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P8Y | |
CY2022Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
1.97 | |
CY2022Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
117542 | shares |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y4M24D | |
CY2022Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
3.13 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
4000 | usd |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-1000 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | usd |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.013 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.097 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.182 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.327 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.041 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.020 | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.000 | |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
1455000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
|
1550000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
294000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
73000 | usd |
CY2022Q4 | efoi |
Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
|
306000 | usd |
CY2021Q4 | efoi |
Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
|
88000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
438000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
49000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
18856000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
17318000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
20764000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
18932000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9200000 | usd |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9600000 | usd |
CY2022Q4 | efoi |
Deferred Tax Assets Operating Loss Carryforwards Portion Available After Application Of Irc Section382 Limitations
DeferredTaxAssetsOperatingLossCarryforwardsPortionAvailableAfterApplicationOfIRCSection382Limitations
|
78000000 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9200000 | usd |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9600000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
|
37500000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | usd |
CY2021Q4 | efoi |
Employer Deferred Payroll Taxes Liability Cares Act
EmployerDeferredPayrollTaxesLiabilityCARESAct
|
77000 | usd |
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.22 | |
CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.22 | |
CY2022 | us-gaap |
Revenues
Revenues
|
5968000 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
9865000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
5968000 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
9865000 | usd |
CY2021Q4 | efoi |
Longlived Assets Locatedin Us Percent
LonglivedAssetsLocatedinUSPercent
|
1 | |
CY2022Q4 | efoi |
Longlived Assets Locatedin Us Percent
LonglivedAssetsLocatedinUSPercent
|
1 | |
CY2021Q3 | efoi |
Payroll Tax Credit Employee Retention Credit Under The Cares Act
PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESAct
|
431000 | usd |
CY2021Q2 | efoi |
Payroll Tax Credit Employee Retention Credit Under The Cares Act Current
PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent
|
445000 | usd |
CY2021Q4 | efoi |
Payroll Tax Credit Employee Retention Credit Under The Cares Act Current
PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent
|
445000 | usd |
CY2021Q4 | efoi |
Payroll Tax Credit Employee Retention Credit Under The Cares Act Current
PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent
|
445000 | usd |
CY2021Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.59 | |
CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.59 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.45 | |
CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.45 | |
CY2021Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5312000 | shares |
CY2021Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5312000 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5086000 | shares |
CY2022Q4 | us-gaap |
Revenues
Revenues
|
663000 | usd |
CY2022Q3 | us-gaap |
Revenues
Revenues
|
1764000 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
1480000 | usd |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
2061000 | usd |
CY2022Q4 | us-gaap |
Gross Profit
GrossProfit
|
-238000 | usd |
CY2022Q3 | us-gaap |
Gross Profit
GrossProfit
|
-163000 | usd |
CY2022Q2 | us-gaap |
Gross Profit
GrossProfit
|
109000 | usd |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
-26000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2310000 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2662000 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2486000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2821000 | usd |
CY2022Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.23 | |
CY2022Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.23 | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.29 | |
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.29 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.35 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.35 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.44 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.44 | |
CY2022Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
9583000 | shares |
CY2022Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9583000 | shares |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9190000 | shares |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
9190000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4211000 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4211000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6437000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6437000 | shares |
CY2021Q4 | us-gaap |
Revenues
Revenues
|
2405000 | usd |
CY2021Q3 | us-gaap |
Revenues
Revenues
|
2749000 | usd |
CY2021Q2 | us-gaap |
Revenues
Revenues
|
2074000 | usd |
CY2021Q1 | us-gaap |
Revenues
Revenues
|
2637000 | usd |
CY2021Q4 | us-gaap |
Gross Profit
GrossProfit
|
189000 | usd |
CY2021Q3 | us-gaap |
Gross Profit
GrossProfit
|
563000 | usd |
CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
393000 | usd |
CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
553000 | usd |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2631000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1140000 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2473000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1642000 | usd |
CY2021Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.50 | |
CY2021Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.50 | |
CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5086000 | shares |
CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4211000 | shares |
CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4211000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3612000 | shares |
CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3612000 | shares |